Clinical Pharmacokinetics of Cytarabine Formulations

Author： Hamada A.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.41, Iss.10, 2002-01, pp. : 705-718

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sumatriptan succinate: pharmacokinetics of different formulations in clinical practice

By Lionetto Luana   Negro Andrea   Casolla Barbara   Simmaco Maurizio   Martelletti Paolo  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2369-2380

Informa Healthcare

Access to resources Recommend Favorite

Extended Release Formulations of Anticonvulsant Medications: Clinical Pharmacokinetics and Therapeutic Advantages

By Collins R.J.   Garnett W.R.  

CNS Drugs, Vol. 14, Iss. 3, 2000-09 ,pp. : 203-212

Adis International

Access to resources Recommend Favorite

Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

By Maldonado Rafael  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1001-1014

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Once-Daily Molsidomine: From Immediate-Release to Prolonged-Release Once-Daily Formulations

By Herchuelz A.  

American Journal of Drug Delivery, Vol. 2, Iss. 2, 2004-01 ,pp. : 131-141

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Safety of Intrathecal Liposomal Cytarabine in Children Aged <3 Years

By Peyrl Andreas  

Clinical Pharmacokinetics, Vol. 48, Iss. 4, 2009-06 ,pp. : 265-271

Adis International

Access to resources Recommend Favorite